NYMX Nymox Pharmaceutical Corp

Nymox Pharmaceutical Corp, along with its subsidiaries, is a biopharmaceutical corporation, engaged in research and development of drugs and diagnostic products for aging population. Its product portfolio consists of Nic alert and Tobac alert.

$0.46  -0.80 (-63.85%)
As of 05/23/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  Bahamas
IPO date:  02/11/2013
Outstanding shares:  90,279,794
Average volume:  327,111
Market cap:   $113,752,540
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   23.97
PS ratio:   0.00
Return on equity:   1,092.37%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy